GNTA (Genenta Science S.p.A. American Depositary Shares) Stock Analysis - AI Report
Genenta Science S.p.A. American Depositary Shares (GNTA) is a publicly traded Healthcare sector company. As of May 21, 2026, GNTA trades at $0.65 with a market cap of $14.90M and a P/E ratio of 0.00. GNTA moved +0.00% today. Year to date, GNTA is -57.07%; over the trailing twelve months it is -85.45%. Its 52-week range spans $0.55 to $10.00. Rallies surfaces GNTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on GNTA?
Rallies AI research for GNTA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
WARRELL RAYMOND P JR sold 8.78M (~$13.17K) on Sep 22, 2011.
WARRELL RAYMOND P JR sold 8.00M (~$15.20K) on Sep 21, 2011.
WARRELL RAYMOND P JR sold 300.47K (~$9.62K) on Mar 25, 2011.
GNTA Analyst Consensus
GNTA analyst coverage data. Average price target: $0.00.
Common questions about GNTA
What is the AI research view on GNTA?
Rallies AI research for GNTA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for GNTA?
Rallies AI research for GNTA combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is GNTA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GNTA. It does not provide personalized investment advice.